Review summary
Teaching objective: Assess a 54-year-old writer with long-held beliefs that former friends are plotting against him, poor sleep, and lifelong difficulty passing urine. Engage him without arguing with or endorsing the beliefs; exclude medical, substance, and neurocognitive causes; distinguish delusional disorder, persecutory type, from paranoid personality disorder, schizophrenia, and a mood disorder with psychotic features (DSM-5-TR); assess the risk of harm to himself and to others at every visit; offer cognitive behavioral therapy for psychosis and an antipsychotic by shared decision-making, accepting a refusal and offering again; and, if he starts one, choose a drug with little anticholinergic effect and follow the metabolic monitoring schedule. In parallel, evaluate chronic incomplete emptying with uroflowmetry, post-void residual, kidney function and ultrasound, retrograde urethrography, and cystoscopy; stop self-dilation; and offer urethroplasty instead of further dilation for a stricture that has recurred for decades (AUA 2023), with his capacity to consent assessed, not assumed absent because of the delusional beliefs. The teaching note contrasts this with his documented lifelong self-treatment with bougies and the disputed causes of his illness.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| June 28, 1712 | Born in Geneva; his mother dies nine days later. | CLM-0001, CLM-0002 |
| Early childhood | Almost continual retention of urine in his early years, by his own account. | CLM-0003 |
| 1748 | Writes of urinary retention, at 36; later treats himself with Daran's bougies for eight or ten years. | CLM-0005, CLM-0004, CLM-0006 |
| 1758 | Frequent retentions with a rupture; a year of languor. | CLM-0007 |
| 1761 | A probe breaks in his urethra. | CLM-0005 |
| January 29, 1763 | Asks in his will that his body be opened after death. | CLM-0008 |
| September 1765 | Stones thrown at his house at Môtiers. | CLM-0010 |
| March 22, 1766 | Settles at Wootton, Staffordshire, and begins the Confessions. | CLM-0010 |
| 1766 to 1767 | Becomes convinced that the man who arranged his stay in England is plotting against him; the two quarrel violently. | CLM-0011 |
| May 1, 1767 | Leaves Wootton and flees to France. | CLM-0012 |
| From 1772 | Writes the Dialogues and tries to leave the manuscript at Notre-Dame. | CLM-0013 |
| 1776 to 1778 | Writes the Reveries of the Solitary Walker. | CLM-0014 |
| July 2, 1778 | Dies suddenly at Ermenonville; apoplexy certified; the autopsy finds no urinary lesion. | CLM-0018, CLM-0017 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Jean-Jacques Rousseau was born in Geneva on June 28, 1712. Geneva had followed the Gregorian calendar since 1701, so the date needs no conversion. | confirmed | Bertram C. Jean Jacques Rousseau. Stanford Encyclopedia of Philosophy supports Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 supports McNutt JP. Hesitant Steps: Acceptance of the Gregorian Calendar in Eighteenth-Century Geneva. Church History 2006;75(3):544-564 context |
| D | His mother, Suzanne Bernard, died nine days after his birth. The 1911 Britannica says she died in childbirth; no cause beyond the birth is recorded. |
confirmed | Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 supports Bertram C. Jean Jacques Rousseau. Stanford Encyclopedia of Philosophy supports |
| D | In the Confessions he wrote that a defect in the bladder caused him an almost continual retention of urine in his early years; that he reached thirty almost without feeling this original infirmity, apart from frequent heats in the bladder; that burning and pain in the loins returned at Venice; and that after a hot summer of journeys on foot he had a violent nephritic colic, after which he never recovered his former health. His own account. Nephritic colic is an eighteenth-century term for severe loin pain, not a modern diagnosis. |
confirmed | Rousseau JJ. The Confessions of Jean Jacques Rousseau, complete (English translation) supports |
| D | In the Confessions he wrote that the surgeon Morand advised him to go to Daran, whose bougies were the only ones that gave him any relief; he bought a great number of them so that he would never be without, and used them often for eight or ten years. His own account of self-treatment with urethral bougies. |
confirmed | Rousseau JJ. The Confessions of Jean Jacques Rousseau, complete (English translation) supports Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports |
| D | His letters show that he spoke of urinary retention from 1748, at 36. In 1761 a probe broke in his urethra and he feared it would cost him his life; he wrote that he could not stop using his probes for a single day and that he had carried a bladder disease since childhood. A surgeon, Brother Côme, succeeded in passing a probe and ruled out a stone. His own letters as quoted in a 2023 history-of-medicine paper. The same paper reports that he thought of suicide after the 1761 accident; this record notes that only as past history and gives no detail. |
confirmed | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports |
| D | He described his trouble as a habitual state: he never passed urine with a full stream, the flow was never wholly stopped, and he judged that the stream grew thinner from year to year and would one day stop altogether. His own description as quoted in a 2023 history-of-medicine paper. |
confirmed | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports |
| D | In 1758 he suffered frequent retentions together with a rupture, and passed the year in a state of languor that made him think he was near the end of his life. Rupture was the term of the time for a hernia; the site is not stated. |
confirmed | Rousseau JJ. The Confessions of Jean Jacques Rousseau, complete (English translation) supports |
| D | In a will dated January 29, 1763, he asked that his body be opened after death, to show that his urinary disorder did not come from a dissolute life. | confirmed | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports Androutsos G, Geroulanos S. La porphyrie aiguë intermittente : une nouvelle hypothèse pour expliquer les troubles urinaires de Jean-Jacques Rousseau. Prog Urol 2000;10(6):1282-1289. PMID 11217576 supports |
| D | By his own account in the Confessions he had five children with Thérèse Levasseur, and all five were taken to the foundling hospital shortly after birth. His own account. The 1911 Britannica records a later doubt that the children existed. No health facts about the children are recorded here. |
confirmed | Rousseau JJ. The Confessions of Jean Jacques Rousseau, complete (English translation) supports Bertram C. Jean Jacques Rousseau. Stanford Encyclopedia of Philosophy supports Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 context |
| D | His books were condemned in 1762; stones were thrown at his house at Môtiers in September 1765; and he came to England in January 1766 at the invitation of a Scottish philosopher. He lived at Wootton, in the parish of Ellastone in rural Staffordshire, from March 22, 1766, to May 1, 1767, in a house belonging to Richard Davenport, and wrote the first part of the Confessions there. | confirmed | Hilyard S, Leach S. A Photogrammetric Survey and Reconstruction of Rousseau's Cave. The Antiquaries Journal 2025;105:246-279 supports Bertram C. Jean Jacques Rousseau. Stanford Encyclopedia of Philosophy supports Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 supports Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports |
| D | In England he became wrongly convinced that the Scottish philosopher who had arranged his stay was at the center of a plot against him, and he feared that the servants were spying on him. The two men quarreled violently, and the 1911 Britannica called his letters of this time those of a lunatic. Documented conduct and beliefs; calling them a delusion is interpretation (see CLM-0015). |
confirmed | Bertram C. Jean Jacques Rousseau. Stanford Encyclopedia of Philosophy supports Hilyard S, Leach S. A Photogrammetric Survey and Reconstruction of Rousseau's Cave. The Antiquaries Journal 2025;105:246-279 supports Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 supports Rousseau, Jean-Jacques (1712-1778) supports |
| D | In May 1767 he fled from England to France, and he later lived in France for a time under the name Renou. | confirmed | Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 supports Rousseau, Jean-Jacques. Gale Contextual Encyclopedia of World Literature supports Hilyard S, Leach S. A Photogrammetric Survey and Reconstruction of Rousseau's Cave. The Antiquaries Journal 2025;105:246-279 supports |
| D | From 1772 he wrote the Dialogues (Rousseau, Judge of Jean-Jacques), a work born of his sense of persecution and long read as evidence of growing paranoia; he meant to leave the manuscript on the high altar of Notre-Dame in Paris but found the chancel fenced off by a locked railing. | confirmed | Rousseau, Jean-Jacques. Gale Contextual Encyclopedia of World Literature supports Rousseau JJ. Rousseau, Judge of Jean-Jacques: Dialogues (Collected Writings of Rousseau, volume 1). Dartmouth College Press; 2001. Publisher's description supports |
| D | His last work, the Reveries of the Solitary Walker (written 1776 to 1778), opens: "Me voici donc seul sur la terre" (So here I am, alone on earth), and says he has been in this strange position for more than fifteen years. His own words. |
confirmed | Rousseau JJ. Les Rêveries du promeneur solitaire, Première Promenade supports Neuchâtel, Bibliothèque publique et universitaire, Ms. R 78: Les Rêveries du promeneur solitaire (1776-1778) supports |
| R | The French psychiatrists Sérieux and Capgras classed him among patients with a delusion of interpretation, and a 2023 history-of-medicine paper judges that by current criteria he had a paranoid delusion that appeared around the age of 45 and grew afterwards, while noting that he had real enemies and real persecution (his books condemned, and expulsion by the Swiss authorities). Retrospective interpretation; no diagnosis was made in his lifetime, and real persecution makes the line between belief and delusion hard to draw. |
possible | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports Androutsos G, Geroulanos S. La porphyrie aiguë intermittente : une nouvelle hypothèse pour expliquer les troubles urinaires de Jean-Jacques Rousseau. Prog Urol 2000;10(6):1282-1289. PMID 11217576 supports |
| R | The cause of his urinary disorder is disputed. Proposed causes include a congenital narrowing of the urethra (Poncet and Leriche, and his own phrase, a defect of conformation), a stricture of the penile urethra (judged most probable in a 2023 paper), a muscular valve at the bladder neck (Mercier), urinary retention of psychological origin (Janet), and acute intermittent porphyria (Androutsos and Geroulanos, 2000). Retrospective diagnoses that disagree with one another and with the autopsy (CLM-0017). |
disputed | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports Androutsos G, Geroulanos S. La porphyrie aiguë intermittente : une nouvelle hypothèse pour expliquer les troubles urinaires de Jean-Jacques Rousseau. Prog Urol 2000;10(6):1282-1289. PMID 11217576 supports |
| D | The autopsy done the day after his death found no stone and no lesion of the kidneys, ureters, bladder, or urethra. The report of the surgeon who opened the body, quoted in a 2000 urology history paper; later writers questioned its methods. |
confirmed | Androutsos G, Geroulanos S. La porphyrie aiguë intermittente : une nouvelle hypothèse pour expliquer les troubles urinaires de Jean-Jacques Rousseau. Prog Urol 2000;10(6):1282-1289. PMID 11217576 supports Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports |
| D | He died suddenly at Ermenonville on July 2, 1778, less than two months after moving to the estate of the Marquis de Girardin; a local inquiry the next day certified death from apoplexy. Rumors of suicide circulated, but an examination of his skull in 1897 found no trace of a bullet wound. Apoplexy is an eighteenth-century term; the exact cause is not known. |
confirmed | Rousseau, Jean Jacques. Encyclopaedia Britannica, 11th edition (1911), volume 23 supports Rousseau, Jean-Jacques. Gale Contextual Encyclopedia of World Literature supports Rousseau, Jean-Jacques (1712-1778) supports |
| D | He distrusted the medicine of his time: in Emile he wrote that he would never call a physician for himself unless his life were in evident danger, and in the Confessions he wrote that the physicians he consulted gave him no relief and weakened him. | confirmed | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports Rousseau JJ. The Confessions of Jean Jacques Rousseau, complete (English translation) supports |
| D | In a letter he wrote that when snow and frost shut him in he split wood to make himself sweat twice a day, the only remedy that had ever given him the least relief. His own words as quoted in a 2023 history-of-medicine paper; the letter is not dated there. |
confirmed | Battin J. Jean-Jacques Rousseau, le malade et le penseur de la médecine. Histoire des sciences médicales 2023;5(1):89-95 supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under way | resolved | confirmed | active | CLM-0011 |
| S | Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy booked | resolved | confirmed | active | CLM-0003, CLM-0004, CLM-0006 |
| S | Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefs | active | confirmed | both_with_link | CLM-0011, CLM-0013, CLM-0014, CLM-0015 |
| S | Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retention | active | confirmed | both_with_link | CLM-0003, CLM-0006, CLM-0016, CLM-0017 |
| S | Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urine | active | confirmed | active | CLM-0007 |
| S | Acute low back strain after splitting firewood, without sciatica, red flags, or urinary retention (bladder scan 20 mL); resolved within three weeks | resolved | confirmed | active | CLM-0020 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-01-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | http://loinc.org · 44261-6 |
| S | 2026-01-20 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | http://loinc.org · 70274-6 |
| S | 2026-01-20 | Total score [MoCA] | 28 | http://loinc.org · 72172-0 |
| S | 2026-01-20 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
| S | 2026-01-20 | Symptom score [AUASI] | 24 | http://loinc.org · 80891-5 |
| S | 2026-01-20 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 5 | http://loinc.org · 81090-3 |
| S | 2026-01-20 | Maximum Urine flow by Uroflowmetry | 6.2 mL/s (low) Reference A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL |
http://loinc.org · 80519-2 |
| S | 2026-01-20 | US Urinary bladder Volume post void | 180 mL (high) Reference <=100 mL |
http://loinc.org · 98856-8 |
| S | 2026-01-20 | Leukocytes [#/area] in Urine sediment by Microscopy high power field | 3 /[HPF] Reference <=5 /[HPF] |
http://loinc.org · 5821-4 |
| S | 2026-01-20 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-01-20 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-01-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 2026-01-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 17 mg/dL Reference 8-23 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-01-20 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-01-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 87 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-01-20 | Glucose [Mass/volume] in Serum or Plasma | 93 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-01-20 | Calcium [Mass/volume] in Serum or Plasma | 9.4 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 2026-01-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference <=41 U/L |
http://loinc.org · 1742-6 |
| S | 2026-01-20 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 2026-01-20 | Leukocytes [#/volume] in Blood by Automated count | 6.2 10*3/uL Reference 3.4-9.6 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-01-20 | Platelets [#/volume] in Blood by Automated count | 238 10*3/uL Reference 135-317 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-01-20 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 mIU/L Reference 0.4-4 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-01-20 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 2026-03-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 2026-03-10 | Symptom score [AUASI] | 22 | http://loinc.org · 80891-5 |
| S | 2026-03-10 | US Urinary bladder Volume post void | 210 mL (high) Reference <=100 mL |
http://loinc.org · 98856-8 |
| S | 2026-03-10 | Leukocytes [#/area] in Urine sediment by Microscopy high power field | 2 /[HPF] Reference <=5 /[HPF] |
http://loinc.org · 5821-4 |
| S | 2026-03-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-03-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 85 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-03-10 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-03-10 | Hemoglobin [Mass/volume] in Blood | 14.4 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 2026-04-21 | Symptom score [AUASI] | 6 | http://loinc.org · 80891-5 |
| S | 2026-04-21 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 2 | http://loinc.org · 81090-3 |
| S | 2026-04-21 | Maximum Urine flow by Uroflowmetry | 21.5 mL/s Reference A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL |
http://loinc.org · 80519-2 |
| S | 2026-04-21 | US Urinary bladder Volume post void | 25 mL Reference <=100 mL |
http://loinc.org · 98856-8 |
| S | 2026-04-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | http://loinc.org · 44261-6 |
| S | 2026-04-21 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-04-21 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 92 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-04-21 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-04-21 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2026-04-21 | Cholesterol [Mass/volume] in Serum or Plasma | 196 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-04-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-04-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 122 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-04-21 | Triglyceride [Mass/volume] in Serum or Plasma | 130 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-04-21 | Waist Circumference at umbilicus by Tape measure | 92 cm Reference Below 102 cm for men |
http://loinc.org · 8280-0 |
| S | 2026-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | http://loinc.org · 44261-6 |
| S | 2026-07-14 | Symptom score [AUASI] | 5 | http://loinc.org · 80891-5 |
| S | 2026-07-14 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 1 | http://loinc.org · 81090-3 |
| S | 2026-07-14 | Maximum Urine flow by Uroflowmetry | 20.8 mL/s Reference A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL |
http://loinc.org · 80519-2 |
| S | 2026-07-14 | US Urinary bladder Volume post void | 30 mL Reference <=100 mL |
http://loinc.org · 98856-8 |
| S | 2026-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.99 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 91 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-07-14 | Glucose [Mass/volume] in Serum or Plasma | 94 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-07-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2026-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 201 mg/dL (high) Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 126 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 138 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-07-14 | Waist Circumference at umbilicus by Tape measure | 93 cm Reference Below 102 cm for men |
http://loinc.org · 8280-0 |
| S | 2026-06-09 | US Urinary bladder Volume post void | 20 mL Reference <=100 mL |
http://loinc.org · 98856-8 |
| S | 2026-09-22 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-09-22 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-01-20 | Body height | 166 cm | 8302-2 | S |
| 2026-01-20 | Body weight | 63.8 kg | 29463-7 | S |
| 2026-01-20 | Body mass index (BMI) [Ratio] | 23.2 kg/m2 | 39156-5 | S |
| 2026-01-20 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 2026-01-20 | Diastolic blood pressure | 82 mm[Hg] | 8462-4 | S |
| 2026-01-20 | Heart rate | 84 /min | 8867-4 | S |
| 2026-01-20 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-01-20 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-01-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-02-03 | Body height | 166 cm | 8302-2 | S |
| 2026-02-03 | Body weight | 63.6 kg | 29463-7 | S |
| 2026-02-03 | Body mass index (BMI) [Ratio] | 23.1 kg/m2 | 39156-5 | S |
| 2026-02-03 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-02-03 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-02-03 | Heart rate | 80 /min | 8867-4 | S |
| 2026-02-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-02-03 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-03-10 | Body height | 166 cm | 8302-2 | S |
| 2026-03-10 | Body weight | 64 kg | 29463-7 | S |
| 2026-03-10 | Body mass index (BMI) [Ratio] | 23.2 kg/m2 | 39156-5 | S |
| 2026-03-10 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 2026-03-10 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-03-10 | Heart rate | 78 /min | 8867-4 | S |
| 2026-03-10 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-10 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-04-21 | Body height | 166 cm | 8302-2 | S |
| 2026-04-21 | Body weight | 63.2 kg | 29463-7 | S |
| 2026-04-21 | Body mass index (BMI) [Ratio] | 22.9 kg/m2 | 39156-5 | S |
| 2026-04-21 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-04-21 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-04-21 | Heart rate | 74 /min | 8867-4 | S |
| 2026-04-21 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-04-21 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-04-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-07-14 | Body height | 166 cm | 8302-2 | S |
| 2026-07-14 | Body weight | 64.4 kg | 29463-7 | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 23.4 kg/m2 | 39156-5 | S |
| 2026-07-14 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-07-14 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-07-14 | Heart rate | 72 /min | 8867-4 | S |
| 2026-07-14 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-07-14 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-06-09 | Body height | 166 cm | 8302-2 | S |
| 2026-06-09 | Body weight | 64 kg | 29463-7 | S |
| 2026-06-09 | Body mass index (BMI) [Ratio] | 23.2 kg/m2 | 39156-5 | S |
| 2026-06-09 | Systolic blood pressure | 134 mm[Hg] | 8480-6 | S |
| 2026-06-09 | Diastolic blood pressure | 84 mm[Hg] | 8462-4 | S |
| 2026-06-09 | Heart rate | 86 /min | 8867-4 | S |
| 2026-06-09 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-06-09 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-09-22 | Body height | 166 cm | 8302-2 | S |
| 2026-09-22 | Body weight | 64.6 kg | 29463-7 | S |
| 2026-09-22 | Body mass index (BMI) [Ratio] | 23.4 kg/m2 | 39156-5 | S |
| 2026-09-22 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 2026-09-22 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-09-22 | Heart rate | 70 /min | 8867-4 | S |
| 2026-09-22 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-22 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: philosopher, novelist, and music copyist; writing his memoirs; his books have caused public controversy, and his previous home abroad was attacked with stones after one of them
- S Living since last spring in a rented country house in a rural valley, arranged by an acquaintance; lives with his long-term partner; no firearms in the house
- S Never smoker; a glass of wine with dinner a few times a week; no cannabis, stimulants, or other drugs; no sleeping tablets
- S Walks two to three hours most days collecting plants; splits firewood, which he says makes him sweat and eases his bladder
- S Supports: his long-term partner at home, his writing, and his daily walks among plants; two old correspondents he still trusts
- S Declined permission for the clinic to speak with anyone else about his health; manages his own affairs
Functional status
- S Independent in all activities of daily living; writing daily; has stopped seeing most acquaintances and opens no letters from people he suspects
Mental status
- S Alert and oriented; neatly but plainly dressed; courteous, watchful, and guarded at first, warmer once he felt heard; speech fluent, faster and louder on the subject of his enemies
- S Mood "hunted and tired"; affect anxious and at times tearful; thought process logical, detailed and circumstantial on the theme of the plot; fixed, non-bizarre beliefs that former friends, publishers, and the people around him are coordinating a campaign to defame him and are opening his mail and messages, held with full conviction; no hallucinations; no thoughts of suicide or of harming anyone; insight into the beliefs absent, insight into his urinary illness good; MoCA 28; Insomnia Severity Index 18 (moderate)
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a day
- S Aripiprazole 5 mg oral tablet, one tablet by mouth each morning
- S Ibuprofen 400 mg oral tablet, one tablet by mouth three times a day with food for up to seven days
Procedures and immunizations
Procedures
- S Kidney, ureter, and bladder ultrasound: normal kidneys without hydronephrosis; bladder wall thickened to 6 mm with trabeculation; post-void residual 190 mL; prostate 24 mL
- S Retrograde urethrogram: a 1.5 cm ring-like narrowing of the proximal bulbar urethra with a lumen of about 8 French; penile urethra normal; no false passage or diverticulum
- S Voiding cystourethrogram: the bladder neck opens normally; the posterior urethra is dilated above the bulbar narrowing; no reflux; bladder trabeculation
- S Flexible cystourethroscopy: meatus normal in position and size (no hypospadias); a pale, dense ring of scar in the proximal bulbar urethra that the 16 French scope could not pass; no tumor or stone seen below it
- S Bulbar urethroplasty by excision and primary anastomosis, his informed choice: 1.5 cm of dense spongiofibrosis excised and the ends joined; 16 French urethral catheter left in place. Pathology: dense fibrosis of the corpus spongiosum without inflammation or malignancy
- S Pericatheter retrograde urethrogram three weeks after urethroplasty: no leak at the anastomosis; catheter removed and he voided well
Immunizations
- S 2019-04-08: Tdap vaccine
- S 2026-09-22: Influenza vaccine, 2026-2027 season
- S 2026-09-22: Recombinant zoster vaccine, dose 1 of 2
- S 2026-09-22: Pneumococcal conjugate vaccine PCV20
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D Early childhood: Almost continual retention of urine in early childhood, which he attributed to a defect in the bladder (CLM-0003)
- D From 1748: Urinary retention reported in his letters, and years of self-treatment with urethral bougies (CLM-0005, CLM-0004)
- D 1758: Frequent retentions with a rupture (hernia), and a year of languor (CLM-0007)
- D 1761: A probe broke in the urethra; he feared for his life (CLM-0005)
- D 1766 to 1767: Beliefs that the man who arranged his stay in England was plotting against him, and that the servants were spying on him (CLM-0011)
Family history
- D mother: Died nine days after his birth; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Sleep at least six hours most nights | 2026-07-14 | completed | About six and a half hours most nights by twelve weeks on aripiprazole |
| Less distress and preoccupation from the beliefs, so that he can write each morning and walk without fear | 2026-07-14 | completed | Preoccupation down from most of the day to under an hour; writing most mornings; the beliefs persist with less conviction |
| Stay in care: keep visits and psychotherapy sessions, with no sudden break in treatment | 2026-12-15 | active | Kept every visit and fourteen of sixteen CBT sessions |
| Pass urine with a free stream without self-dilation: maximum flow above 15 mL/s and post-void residual below 100 mL within three months of surgery | 2026-07-14 | completed | Maximum flow 20.8 mL/s and residual 30 mL four months after urethroplasty; no sounds used since January |
| No harm to himself or anyone else; safety plan kept current | 2026-12-15 | active | No suicidal or violent thoughts at any visit; safety plan reviewed at each visit |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Engagement without confrontation: listen to his account in full, acknowledge his distress and the real conflicts in his life, neither argue with nor agree with the beliefs, and agree shared goals that matter to him (sleep, less distress, freedom to write, and his bladder); give him copies of his results and notes | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 |
| Look for medical, substance, and neurocognitive causes: neurological examination, MoCA, blood count, metabolic panel, calcium, TSH, and vitamin B12; review of medicines and alcohol; brain imaging only if the course or examination is atypical | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 |
| Psychiatry consultation to confirm the diagnosis and the differential, assess the risk of harm to himself and others, advise on an antipsychotic and on cognitive behavioral therapy for psychosis, and assess his capacity to consent to urethral surgery | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 |
| Structured suicide and violence risk assessment with a written safety plan and the 988 Suicide & Crisis Lifeline; no firearms in the home; risk reviewed at every visit; signs for urgent care written down with him | completed | GL-SUICIDE-2024 |
| Urology assessment: IPSS, uroflowmetry, bladder scan for post-void residual, urinalysis, and creatinine now, and kidney and bladder ultrasound this week; retrograde urethrogram, voiding cystourethrogram, and flexible cystoscopy by the urology team next week; stop self-dilation with urethral sounds (urethral rest) and come in the same day if he cannot pass urine | completed | GL-AUA-USD-2023 |
| Right inguinal hernia: watchful waiting while it is minimally symptomatic, with the warning signs of incarceration explained; reassess once the straining has been relieved | completed | GL-HERNIA-2018 |
| Sleep: fixed rising time, daylight walks, no writing about his enemies after 8 pm, and no sedating antihistamines or anticholinergic sleep aids, which can worsen urinary retention | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 |
| Cognitive behavioral therapy for psychosis with the clinic psychologist, about 16 weekly to fortnightly sessions, aimed at distress, worry, sleep, and checking and safety behaviors rather than at disproving the beliefs | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 |
| Antipsychotic offered by shared decision-making: aripiprazole 5 mg daily recommended, for its low anticholinergic, sedative, and metabolic effects; he declined it at the consultation and the offer stays open; no compulsory treatment while he remains safe | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 |
| Bulbar urethroplasty by excision and primary anastomosis, his choice after dilation, internal urethrotomy, and self-catheterization had been explained; urethral rest until surgery; capacity to consent confirmed; catheter for three weeks with a pericatheter urethrogram before removal; acetaminophen rather than opioids afterwards | completed | GL-AUA-USD-2023 |
| Aripiprazole 5 mg each morning, started at his request; weight at 4, 8, and 12 weeks then quarterly; blood pressure, fasting glucose or hemoglobin A1c, and lipids at baseline and 12 weeks then yearly; waist at baseline and yearly; akathisia check at each visit; AIMS at baseline and every 6 months | completed | GL-CMID-2026, GL-APA-SCZ-2020 |
| Surveillance after urethroplasty: symptoms and IPSS, uroflowmetry, and post-void residual at about 3, 6, and 12 months; urethroscopy or a urethrogram only if symptoms return or the flow falls | completed | GL-AUA-USD-2023 |
Planned encounters
- 2026-01-20 — Primary care visit for beliefs of being plotted against, poor sleep, and difficulty passing urine (ENC-001)
- 2026-02-03 — Psychiatry consultation and review of the urethral imaging and cystoscopy (ENC-002)
- 2026-03-10 — Seven-week review of psychotherapy and safety, and preparation for urethroplasty (ENC-003)
- 2026-04-21 — Review four weeks after urethroplasty; start of aripiprazole (ENC-004)
- 2026-06-09 — Same-day sick visit for low back pain (ENC-006, unscheduled)
- 2026-07-14 — Twelve-week aripiprazole and urethroplasty follow-up (ENC-005)
- 2026-09-22 — Adult preventive visit (ENC-007)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Sick Visit
- Progress note 06 — Focused Visit (Care-plan review)
- Progress note 07 — Preventive Visit
- Psychiatry referral
- Psychiatry consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Sick Visit (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Progress note 07 — Preventive Visit (XML)
- Psychiatry referral (XML)
- Psychiatry consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the delusional disorder differential, the violence and suicide risk review, the declined and later accepted aripiprazole with its monitoring, the capacity assessment, the choice of anastomotic urethroplasty over further dilation, and the recorded deviations. |
| provenance review | not_started | Stanford Encyclopedia of Philosophy, the 1911 Britannica, the Confessions (Gutenberg), the Reveries (Wikisource) and its manuscript record, two history-of-medicine papers read in full (2000 and 2023), a 2025 archaeological paper on Wootton, two encyclopedia entries, and a publisher's description. His beliefs are D; calling them a delusion is R. The cause of his urinary illness is R (disputed) and the autopsy found no lesion (D). The Scottish philosopher who arranged his stay in England is not named, because he has his own record. |
| safe messaging review | not_started | Synthetic safety assessment with no current suicidal or violent ideation. A past thought of suicide in 1761 is mentioned only as history, without detail. The 1778 suicide rumor is recorded with the evidence against it. The children left at the foundling hospital are documented history only, with no health facts. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.